Literature DB >> 29381434

Effect of Hepatitis B and C Infection on Recruitment for Cancer Clinical Trials.

Murali Janakiram1, Sakshi Jasra1, David Aboulafia1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29381434      PMCID： PMC9405303          DOI： 10.1200/JCO.2017.76.9307

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   50.717


× No keyword cloud information.
  8 in total

1.  Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study.

Authors:  Harrys A Torres; Jeff Hosry; Parag Mahale; Minas P Economides; Ying Jiang; Anna S Lok
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

2.  How I treat hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; George B McDonald
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

Review 3.  Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.

Authors:  Man Fai Law; Rita Ho; Carmen K M Cheung; Lydia H P Tam; Karen Ma; Kent C Y So; Bonaventure Ip; Jacqueline So; Jennifer Lai; Joyce Ng; Tommy H C Tam
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.

Authors:  Cindy M Weinbaum; Eric E Mast; John W Ward
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 5.  Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.

Authors:  Rohit Loomba; Ayana Rowley; Robert Wesley; T Jake Liang; Jay H Hoofnagle; Frank Pucino; Gyorgy Csako
Journal:  Ann Intern Med       Date:  2008-04-01       Impact factor: 25.391

6.  Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.

Authors:  Wai-Kay Seto; Thomas S Y Chan; Yu-Yan Hwang; Danny Ka-Ho Wong; James Fung; Kevin Sze-Hang Liu; Harinder Gill; Yuk-Fai Lam; Albert K W Lie; Ching-Lung Lai; Yok-Lam Kwong; Man-Fung Yuen
Journal:  J Clin Oncol       Date:  2014-10-06       Impact factor: 44.544

7.  Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.

Authors:  Thomas S Uldrick; Gwynn Ison; Michelle A Rudek; Ariela Noy; Karl Schwartz; Suanna Bruinooge; Caroline Schenkel; Barry Miller; Kieron Dunleavy; Judy Wang; Jerome Zeldis; Richard F Little
Journal:  J Clin Oncol       Date:  2017-10-02       Impact factor: 44.544

8.  Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update.

Authors:  Jessica P Hwang; Mark R Somerfield; Devena E Alston-Johnson; Donna R Cryer; Jordan J Feld; Barnett S Kramer; Anita L Sabichi; Sandra L Wong; Andrew S Artz
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.